A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
Source
The journal of antimicrobial chemotherapy - ISSN 0305-7453-81:4 (2026) p. 1-14
Discovery of a series of macrocycles as potent inhibitors of Leishmania infantum
Source
Journal of medicinal chemistry - ISSN 0022-2623-67:20 (2024) p. 18170-18193
In vivo bioluminescence imaging reveals differences in Leishmania infantum parasite killing kinetics by antileishmanial reference drugs
Source
ACS Infectious Diseases - ISSN 2373-8227-10:6 (2024) p. 2101-2107
Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites
Source
PLoS pathogens - ISSN 1553-7374-20:4 (2024) p. 1-21
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
Source
Nature communications - ISSN 2041-1723-15:1 (2024) p. 1-18